This is a protocol preprint. Preprints are preliminary reports that have not undergone peer review. They should not be considered conclusive, used to inform clinical practice, or referenced by the media as validated information.
Method Article
Trans-well migration assay
Ofer Mandelboim
The Hebrew University of Jerusalem
Corresponding Author
License:
This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License
In vitro migration assay
Transwell in vitro migration assays.
1) Place 150 x 103 isolated human trophoblasts in the upper chamber of 8 micron Transwells, (Costar Inc) on 100µl of solid growth factor reduced Matrigel (BD Biosciences, Bedford, MA).
2) Place different NK cell subsets (100 x 103 cells in 600 µl of Bio-MPM-1 medium (Biological Industries, Beit Haemek, Israel) supplemented with 5 U/ml of IL-15 and 5% pen-strep and non-essential amino acids) in the lower chamber for five days.
3) Where neutralizing antibodies for chemokines are to be used, add to the lower chambers (anti-IL-8, anti-IP-10, anti-SDF1 and anti-Eotaxin mAbs; all from RnD systems) at a concentration of 5µg/ml each.
4) Induce NK subset ability to induce HUVECs migration by placing NK derived supernatants or control media in the lower chamber of Transwell inserts with 6.5µm pores.
5) Plate HUVECs (5 X 104) in the upper chamber, and allowed to migrate for 4 hours at 37oC.
6) At the end of the trophoblast or HUVEC migration assays, cleanse the filter side of the upper chamber with a cotton swab and stain the filter for one hour with crystal violet (Sigma) in 2% ethanol and then rinse in water.
7) Gently cut the filter from the chamber and count the cells that have migrated through the filter pores from the underside of the filter.
8) Count the number of cells that migrated across the filters in 4 high-power fields per insert, and average values afterwards. For each migration condition, three identical replicates should be performed.
Version History
CURRENT STATUS: Posted
Version 1
Posted 07 Aug, 2006
Metrics
Comments: 0
HTML Views: ...
Associated Publications
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
by Hanna, J. et al.
Nature Medicine (09 June, 2006)
Method Article
Trans-well migration assay
Ofer Mandelboim
The Hebrew University of Jerusalem
Corresponding Author
Version History
CURRENT STATUS: Posted
Version 1
Posted 07 Aug, 2006
Metrics
Comments: 0
HTML Views: ...
License:
This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License
In vitro migration assay
Transwell in vitro migration assays.
1) Place 150 x 103 isolated human trophoblasts in the upper chamber of 8 micron Transwells, (Costar Inc) on 100µl of solid growth factor reduced Matrigel (BD Biosciences, Bedford, MA).
2) Place different NK cell subsets (100 x 103 cells in 600 µl of Bio-MPM-1 medium (Biological Industries, Beit Haemek, Israel) supplemented with 5 U/ml of IL-15 and 5% pen-strep and non-essential amino acids) in the lower chamber for five days.
3) Where neutralizing antibodies for chemokines are to be used, add to the lower chambers (anti-IL-8, anti-IP-10, anti-SDF1 and anti-Eotaxin mAbs; all from RnD systems) at a concentration of 5µg/ml each.
4) Induce NK subset ability to induce HUVECs migration by placing NK derived supernatants or control media in the lower chamber of Transwell inserts with 6.5µm pores.
5) Plate HUVECs (5 X 104) in the upper chamber, and allowed to migrate for 4 hours at 37oC.
6) At the end of the trophoblast or HUVEC migration assays, cleanse the filter side of the upper chamber with a cotton swab and stain the filter for one hour with crystal violet (Sigma) in 2% ethanol and then rinse in water.
7) Gently cut the filter from the chamber and count the cells that have migrated through the filter pores from the underside of the filter.
8) Count the number of cells that migrated across the filters in 4 high-power fields per insert, and average values afterwards. For each migration condition, three identical replicates should be performed.
Associated Publications
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface
by Hanna, J. et al.
Nature Medicine (09 June, 2006)